Latest News and Press Releases
Want to stay updated on the latest news?
- 
                            
Savara stock declined 31.7% after the FDA declined to file its MOLBREEVI application, citing incomplete chemistry, manufacturing, and controls information.
 - 
                            
Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics (MLTX) Mislead Investors Regarding the Efficacy of its Drug Candidate
 - 
                            
Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate
 - 
                            
Robbins LLP is Investigating Allegations that WPP PLC (WPP) Mislead Investors Regarding its Business Prospects
 - 
                            
Robbins LLP is Investigating Allegations that Marex Group PLC (MRX) Mislead Investors Regarding its Revenue Projections
 - 
                            
Robbins LLP is Investigating Allegations that Spirit Aviation Holdings, Inc. (FLYYQ) Failed to Disclose it would be Required to File for Bankruptcy
 - 
                            
Robbins LLP is Investigating Allegations that Cepton, Inc. (CPTN) Misled Investors in Connection with the Company's Acquisition by Koito Manufacturing Co.,
 - 
                            
Robbins LLP is Investigating Allegations that C3.ai, Inc. (AI) Misled Investors Regarding the Impact of its CEO's Health on its Business Prospects
 - 
                            
Robbins LLP is Investigating Allegations that Molina Healthcare, Inc. (MOH) Mislead Investors Regarding its Business Prospects.
 - 
                            
: Robbins LLP is Investigating Allegations that Spirit Aviation Holdings, Inc. (FLYYQ) Failed to Disclose it would be Required to File for Bankruptcy